ABOUT COMPANY
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California.
|
EARNINGS
Gross Profit (TTM): 40503000
Market Capitalization: 1118089000
Operating Margin (TTM): -0.419
PE Ratio: None
PEG Ratio: -0.23
Profit Margin: -0.974
Revenue Per Share (TTM): 0.332
Revenue (TTM): 81370000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.447
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.323
Dividend Date: 2017-03-03
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -52871000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|